Positron Corp
Positron Corp is a U.S.-based medical technology company focused on PET and PET-CT imaging systems for nuclear medicine. The company develops, manufactures, and sells imaging equipment and supports customers with maintenance services, clinical support, and related commercial arrangements from its headquarters in North Tonawanda, New York.
Fiscal year 2025 · change from previous year
Development 2025–2025
Business
Share of revenueCapital equipment used for molecular imaging in cardiac, oncology, and neurology applications.
Recurring service agreements that provide ongoing support and system uptime for installed equipment.
Customers
Positron sells to healthcare providers that use molecular imaging for diagnosis and treatment planning, especially in nuclear cardiology. Its customer base includes hospitals, outpatient centers, and physician practices that need PET and PET-CT systems plus ongoing service support. The company also works through OEM and distribution arrangements that extend market access for its imaging platforms.
Buy PET and PET-CT systems for inpatient and outpatient diagnostic imaging and long-term service support.
Purchase systems and maintenance contracts to offer molecular imaging without building in-house technology.
Use Positron systems for specialized nuclear cardiology workflows and recurring service coverage.
Support broader commercialization and market reach for PET and PET-CT products.
Strategy
Positron’s strategy centers on expanding its PET-CT offering, broadening use in nuclear cardiology, and supporting commercialization through manufacturing and distribution partnerships. The company also relies on external capital to fund operations while it builds revenue scale and expands clinical adoption of its imaging systems.
Broader adoption is central to scaling the installed base and creating recurring service revenue.
Oncology and neurology can enlarge the addressable market and reduce dependence on one specialty.
Maintenance contracts improve customer retention and support the value proposition of installed equipment.
Geography
Positron is headquartered in North Tonawanda, New York and is organized as a U.S. company. The reports emphasize North American commercialization, including an exclusive North American distribution right tied to its PET and PET-CT product line. Geography matters because the company’s market access, regulatory pathway, and installed-base service model are concentrated in the U.S. healthcare market.
Risks
Positron faces execution risk in commercializing its imaging systems, including customer adoption, competitive pressure, and the need to secure financing to support operations. Because the business depends on equipment sales plus service contracts, delays in equipment acceptance or slower market uptake can affect revenue timing and cash generation. The company also depends on healthcare capital spending and regulatory/clinical acceptance in a specialized medical imaging market.
The company states it may need additional capital to continue operations and fund growth.
Exposure: Operating continuity and commercialization funding
PET and PET-CT systems require clinical acceptance and buyer confidence before scaling.
Exposure: Equipment sales and installed-base growth
The imaging market includes established competitors with broader product portfolios and sales reach.
Revenue is recognized only when control transfers, so delayed delivery or acceptance postpones revenue.
Exposure: Quarterly revenue volatility
Accounting
Judgemental itemsMaintenance contracts are over-time revenue while equipment sales are point-in-time, affecting period comparability.
Impact: Reported revenue depends on service periods and equipment delivery/acceptance
Advance customer payments are recorded as liabilities until services are delivered.
Impact: Affects balance sheet liabilities and future revenue visibility
Management identifies this as a critical estimate area requiring judgment.
Impact: Can affect classification, dilution analysis, and equity balances
Similar listed companies
Publicly listed companies with a comparable business focus.
iTonic Holdings Ltd
ITOC · Electromedical & Electrotherapeutic Apparatus
iTonic Holdings Ltd is a U.S.-listed healthcare solutions company organized around Beijing Feitian Zhaoye Technology Co., Ltd., its wholly owned operating subsidiary in Beijing, China.
Purple Biotech Ltd
PPBT · Pharmaceutical Preparations
Vivos Inc
RDGL · Surgical & Medical Instruments & Apparatus
Lantheus Holdings, Inc.
LNTH · In Vitro & In Vivo Diagnostic Substances
Sotera Health Co
SHC · Services-Misc Health & Allied Services, NEC
Sotera Health is a U.S.-based provider of sterilization, laboratory testing, and advisory services for healthcare and life-science supply chains.
VolitionRX Limited
VNRX · In Vitro & In Vivo Diagnostic Substances
VolitionRx Ltd is a U.S.-based epigenetics diagnostics company developing blood-based tests that use nucleosomes and related biomarkers to detect and monitor disease.
Last updated: 24/09/2026